RxDoctor Payments Data

Stephany Manurung

Psychiatric/Mental Health · Orange, CANPI 1669065660

Payments from drug & device makers

$3,785in general payments, 2019–2025

Across 198 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$746
  • Otsuka America Pharmaceutical, Inc.$709
  • Takeda Pharmaceuticals U.S.A., Inc.$595
  • Lundbeck LLC$462
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$393
  • Axsome Therapeutics, Inc.$312
  • plus $568 from 8 others

What the payments were for

  • Food & beverage$3,785100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,785 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Medicare billing

Part B allowed, 2024
$18,218
Medicare patients
29
Services billed
236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$18,291
Trazodone Hcl33$2,108
Duloxetine Hcl21$1,668
Vilazodone Hcl12$1,293
Desvenlafaxine Succinate ErDesvenlafaxine Succinate22$1,124
Bupropion XlBupropion Hcl16$626
Buspirone Hcl26$599
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine22$553
Hydroxyzine Hcl17$443
Alprazolam38$391
Bupropion Hcl SrBupropion Hcl18$307
Carbamazepine12$244
Fluoxetine Hcl22$236
Lorazepam46$228
Gabapentin28$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$746$18,29112 claims
Almatica Pharma LLCSertraline Hcl$158$7315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →